U.S., Jan. 28 -- An application to own the trademark for 'GLYPHALLO' has been filed on Aug. 14, 2025.
Owner(s):
Seaport Therapeutics, Inc.; 101 Seaport Blvd., Floor 12, MASSACHUSETTS
Goods and/or Services:
For: Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabo...